
Results
2168
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2168 companies
Atomo Diagnostics
Market Cap: AU$15.3m
Engages in the development and sale of medical devices worldwide.
AT1
AU$0.017
7D
-5.6%
1Y
-5.6%
Aspire Biopharma Holdings
Market Cap: US$11.0m
An early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States.
ASBP
US$8.27
7D
8.2%
1Y
-98.7%
LexaGene Holdings
Market Cap: CA$14.8m
LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems.
LXG.H
CA$0.10
7D
0%
1Y
-43.2%
Quoin Pharmaceuticals
Market Cap: US$10.9m
A late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.
QNRX
US$5.07
7D
2.0%
1Y
-31.3%
Vistagen Therapeutics
Market Cap: US$10.8m
A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders.
VTGN
US$0.25
7D
2.6%
1Y
-92.0%
Theriva Biologics
Market Cap: US$10.8m
A clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States.
TOVX
US$0.24
7D
5.3%
1Y
-43.4%
HeartSciences
Market Cap: US$10.8m
A medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence.
HSCS
US$3.00
7D
40.8%
1Y
-13.0%
Ceryvyn Therapeutics
Market Cap: AU$15.0m
A clinical-stage biopharmaceutical company, researches and develops therapeutic products based on targeting vascular endothelial growth factors (VEGF) C, D and R3 in Australia and the United States.
CYV
AU$0.011
7D
0%
1Y
n/a
Hemostemix
Market Cap: CA$14.8m
A clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.
HEM
CA$0.07
7D
-6.7%
1Y
-12.5%
ALR Technologies SG
Market Cap: US$10.7m
A data management company, provides diabetes care management solutions.
ALRT.F
US$0.017
7D
-10.5%
1Y
78.9%
Aurora Spine
Market Cap: CA$14.7m
Through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada.
ASG
CA$0.19
7D
-13.6%
1Y
-36.7%
Bullfrog AI Holdings
Market Cap: US$10.4m
Operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States.
BFRG
US$0.58
7D
9.0%
1Y
-53.6%
Non-Invasive Monitoring Systems
Market Cap: US$10.3m
Does not have significant operations.
NIMU.D
US$10.00
7D
8.0%
1Y
1,349.3%
Red White & Bloom Brands
Market Cap: CA$14.1m
Manufactures and distributes cannabis products and accessories in the United States, Canada, and internationally.
RWB
CA$0.03
7D
0%
1Y
n/a
Sintx Technologies
Market Cap: US$10.2m
An advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States.
SINT
US$1.56
7D
-3.7%
1Y
-59.0%
United Health Products
Market Cap: US$10.2m
Develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States.
UEEC
US$0.037
7D
-10.8%
1Y
-59.4%
Aprea Therapeutics
Market Cap: US$10.1m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.
APRE
US$0.95
7D
41.4%
1Y
-39.9%
MetaVia
Market Cap: US$10.1m
A clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases.
MTVA
US$1.64
7D
10.1%
1Y
-76.3%
Lotus Pharmaceuticals
Market Cap: US$10.0m
Does not have significant operations.
LTUS
US$0.0032
7D
-15.8%
1Y
-64.6%
AEON Biopharma
Market Cap: US$9.8m
A clinical stage biopharmaceutical company, focuses on developing botulinum toxins.
AEON
US$0.21
7D
-13.5%
1Y
-72.0%
CONNEQT Health
Market Cap: AU$13.6m
Engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific.
CQT
AU$0.015
7D
-11.8%
1Y
-46.4%
Medicure
Market Cap: CA$13.4m
A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.
MPH
CA$1.30
7D
0%
1Y
13.0%
Lunai Bioworks
Market Cap: US$9.7m
A pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands.
LNAI
US$2.20
7D
1.6%
1Y
-88.1%
Lucyd
Market Cap: US$9.6m
Develops and sells smart eyewear in North America.
LUCY
US$1.07
7D
50.5%
1Y
-45.7%
Greenway Greenhouse Cannabis
Market Cap: CA$13.3m
Engages in the cultivation, processing, sale, bulk package, and wholesale of dry bud cannabis.
GWAY
CA$0.10
7D
11.1%
1Y
-50.0%
TruScreen Group
Market Cap: NZ$16.1m
Develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Central Asia, Vietnam, Zimbabwe, Indonesia, India, and the Middle East/North Africa.
TRU
NZ$0.015
7D
0%
1Y
-11.8%
Skye Bioscience
Market Cap: US$9.6m
A clinical-stage biotechnology company, develops molecules that modulate G-protein-coupled receptors to treat obesity, overweight, and related metabolic diseases.
SKYE
US$2.02
7D
-29.8%
1Y
-93.0%
Scientific Industries
Market Cap: US$9.5m
Engages in the design, manufacture, and marketing of standard benchtop laboratory equipment, weight and measurement, and bioprocessing products in the United States, Germany, and internationally.
SCND
US$0.80
7D
14.7%
1Y
9.8%
American Shared Hospital Services
Market Cap: US$9.5m
Provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services.
AMS
US$1.47
7D
-2.6%
1Y
-40.7%
ReNerve
Market Cap: AU$13.3m
A medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures.
RNV
AU$0.077
7D
0%
1Y
-23.0%
Rapid Dose Therapeutics
Market Cap: CA$13.0m
A life sciences company, provides drug delivery technologies in Canada.
DOSE
CA$0.11
7D
10.0%
1Y
-37.1%
GENinCode
Market Cap: UK£6.8m
Engages in the development and commercialization of clinical genetic tests for predictive analysis of risk to a patient’s health based on genes in the United Kingdom, Spain, Italy, the United States, Germany, and internationally.
GENI
UK£0.009
7D
0%
1Y
-35.7%
Cardiogeni
Market Cap: UK£6.7m
A clinical stage biotechnology company, develops heart failure medicines.
CGNI
UK£0.07
7D
0%
1Y
-6.7%
CompuMed
Market Cap: US$9.2m
Provides diagnostic telemedicine solutions in the United States.
CMPD
US$6.86
7D
1.6%
1Y
44.7%
Seegnal
Market Cap: CA$12.7m
Provides SaaS clinical division support solutions.
SEGN
CA$0.28
7D
0%
1Y
n/a
PharmaCielo
Market Cap: CA$12.7m
Together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada.
PCLO
CA$0.06
7D
9.1%
1Y
n/a